News

Published on 15 Mar 2024 on Zacks via Yahoo Finance

Charles River (CRL) Extends Gene Therapy Offering With New Pact

Article preview image

Charles River Laboratories International, Inc. CRL inked an AAV9 production program deal with Navega Therapeutics. The deal will grant Navega Therapeutics access to Charles River’s contract development and manufacturing capabilities and advisory services to produce the AAV gene therapy candidate NT-Z001 for phase 1 clinical trials.

The recent move will bolster Charles River’s Biologics Solutions.

More on the News

Read the rest of the article
NYSE.CRL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Charles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y

Charles River Laboratories International, Inc. CRL reported first-quarter 2024 adjusted earnings ...

Zacks via Yahoo Finance 9 May 2024
Charles River Posts Q1 Adjusted EPS Beat, Narrow Guidance Range By Investing.com

Charles River Laboratories International, Inc. (NYSE: CRL) reported a solid start to 2024, with...

Investing.com 9 May 2024
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect

Charles River Laboratories International, Inc. CRL is scheduled to report first-quarter 2024 resu...

Zacks via Yahoo Finance 24 Apr 2024
Quant Ratings Updated on 113 Stocks

Alphabet, Inc. (GOOGL), Meta Platforms, Inc. (META), Microsoft Corporation (MSFT) and Tesla, Inc....

InvestorPlace 23 Apr 2024
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new ...

Zacks via Yahoo Finance 23 Apr 2024
Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock Is Going Strong: Is the Market...

Charles River Laboratories International (NYSE:CRL) has had a great run on the share market with ...

Simply Wall St. via Yahoo Finance 1 Apr 2024
Charles River (CRL) Extends Gene Therapy Offering With New Pact

Charles River Laboratories International, Inc. CRL inked an AAV9 production program deal with Nav...

Zacks via Yahoo Finance 15 Mar 2024
Here's Why You Should Retain Charles River (CRL) Stock Now

Charles River Laboratories International, Inc. CRL is well-poised to grow in the coming quarters,...

Zacks via Yahoo Finance 14 Mar 2024
Insider Sell: CSVP & Chief Accounting Officer Michael Knell Sells Shares of Charles River ...

Charles River Laboratories International Inc (NYSE:CRL), a global provider of essential products ...

GuruFocus.com via Yahoo Finance 12 Mar 2024
Calculating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Key Insights Charles River Laboratories International's estimated fair value is US$328 based on 2...

Simply Wall St. via Yahoo Finance 7 Mar 2024

Copyright Statfolio @ 2024

Social Accounts